Sauna use, depression and addiction — the dynorphin thermoregulatory connection | Roland Griffiths
Posted on
November 5th 2019
(over 3 years)
SHARE
Love our episodes? Subscribe to our channels
Get email updates with the latest curated healthspan research
Support our work
Every other week premium members receive a special edition newsletter that summarizes all of the latest healthspan research.
Psychedelic News
- A single dose of psilocybin enhanced creative thinking, empathy, and subjective well-being in participants for up to seven days after use.
- Serotonin 5-HT2A receptor activation (molecular target of classical psychedelics) suppresses TNF-alpha-induced inflammation with extraordinary potency
- Psychedelic drugs shown to cause a greater number of patterns of activation in the brain at a given time, and also induce patterns similar to sleep
- Classic psychedelic use protective with regard to psychological distress and suicidality
- Psychedelics and immunomodulation: Novel approaches and therapeutic opportunities
